Prevalence of potential drug-drug interactions and associated factors among elderly patients in Ethiopia: a systematic review and meta-analysis

被引:0
作者
Alemayehu, Tekletsadik Tekleslassie [1 ]
Wassie, Yilkal Abebaw [5 ]
Bekalu, Abaynesh Fentahun [2 ]
Tegegne, Addisu Afrassa [4 ]
Ayenew, Wendim [1 ]
Tadesse, Gebresilassie [7 ]
Getachew, Demis [3 ]
Yazie, Abebaw Setegn [9 ]
Teketelew, Bisrat Birke [6 ]
Mekete, Mekonnen Derese [1 ,11 ]
Fentahun, Setegn [7 ]
Abebe, Tesfaye Birhanu [8 ]
Minwagaw, Tefera [1 ,10 ]
Geremew, Gebremariam Wulie [2 ]
机构
[1] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Social & Adm Pharm, Gondar, Ethiopia
[2] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm, Gondar, Ethiopia
[3] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Pharmacol, Gondar, Ethiopia
[4] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Pharmaceut Chem, Gondar, Ethiopia
[5] Univ Gondar, Coll Med & Hlth Sci, Sch Nursing, Dept Med Nursing, Gondar, Ethiopia
[6] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Gondar, Ethiopia
[7] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Psychiat, Gondar, Ethiopia
[8] Univ Gondar, Sch Med, Dept Internal Med, Coll Med & Hlth Sci, Gondar, Ethiopia
[9] Univ Gondar, Dept Med Parasitol, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Gondar, Ethiopia
[10] Bahir Dar Univ, Dept Pharm, Bahir Dar, Ethiopia
[11] Debremarkos Univ, Dept Pharm, Debremarkos, Ethiopia
关键词
Prevalence; Potential drug-drug interaction; Associated factors; Elderly; Ethiopia; HOSPITALIZED-PATIENTS; CARDIOVASCULAR-DISEASES; POLYPHARMACY; FREQUENCY; ONCOLOGY;
D O I
10.1186/s41256-024-00386-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThe occurrence of potential drug-drug interactions (pDDIs) is a serious global issue that affects all age groups, with the elderly population being the most vulnerable. This is due to their relatively high rates of comorbidity and polypharmacy, as well as physiological changes that can increase the potential for DDIs and the likelihood of adverse drug reactions. The aim of this study was to estimate the prevalence of pDDIs and associated factors among elderly patients in Ethiopia.MethodsA comprehensive literature search using the preferred reporting items for systematic review and meta-analysis statement was conducted on HINARI, Science Direct, Embase, PubMed/MEDLINE, Google Scholar, and Research Gate. Data were extracted via a Microsoft Excel spreadsheet and analyzed via STATA version 11.0. Egger regression tests and funnel plot analysis were used to check publication bias, and the I2 statistic was used to evaluate statistical heterogeneity. Sensitivity and subgroup analyses were also conducted to identify potential causes of heterogeneity.ResultsSeven articles were analyzed, and a total of 1897 pDDIs were identified in 970 patients, resulting in an average of 1.97 DDIs per patient. The number of DDIs per patient ranged from 0.18 to 5.86. The overall prevalence of pDDIs among elderly patients was 50.69% (95% CI 18.77-82.63%). However, the prevalence of pDDIs ranged widely from 2.80 to 90.1%. When the severity of the interactions was considered, the prevalence of potential DDIs was found to be 28.74%, 70.68%, and 34.20% for major, moderate, and minor pDDIs, respectively. Polypharmacy and long hospital stays were identified as factors associated with pDDIs among elderly patients in Ethiopia.ConclusionsThe overall prevalence of pDDIs among elderly patients was high, with a wide range of prevalence rates. Moderate-severity interactions were the most prevalent. Polypharmacy and long hospital stays were identified as factors associated with pDDIs among elderly patients. The study suggests that DDIs identification database itself could have modified the DDIs prevalence rate. As a result, a single DDIs identification database needs to be authorized; otherwise, clinical knowledge should be taken into account when interpreting the information obtained.
引用
收藏
页数:13
相关论文
共 53 条
  • [1] Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia
    Adem, Limi
    Tegegne, Gobezie T.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2022, 17 : 509 - 517
  • [2] Prevalence of drug-drug interactions in geriatric patients at an ambulatory care pharmacy in a tertiary care teaching hospital
    Aljadani R.
    Aseeri M.
    [J]. BMC Research Notes, 11 (1)
  • [3] Alssageer MA., 2023, Mediterr J Pharm Pharm Sci, V2, P66
  • [4] Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia
    Assefa, Yelbeneh Abayneh
    Kedir, Ansha
    Kahaliw, Wubayehu
    [J]. INTEGRATED PHARMACY RESEARCH AND PRACTICE, 2020, 9 : 1 - 9
  • [5] Prevalence of potential drug-drug interactions and associated factors among outpatients and inpatients in Ethiopian hospitals: a systematic review and meta-analysis of observational studies
    Ayenew, Wondim
    Asmamaw, Getahun
    Issa, Arebu
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01)
  • [6] The incidence of potential drug-drug interactions in elderly patients with arterial hypertension
    Bacic-Vrca, Vesna
    Marusic, Srecko
    Erdeljic, Viktorija
    Falamic, Slaven
    Gojo-Tomic, Nives
    Rahelic, Dario
    [J]. PHARMACY WORLD & SCIENCE, 2010, 32 (06): : 815 - 821
  • [7] Bastida C, 2017, FARM HOSP, V41, P618, DOI 10.7399/fh.10778
  • [8] Hospitalisations and emergency department visits due to drug-drug interactions: a literature review
    Becker, Matthijs L.
    Kallewaard, Marjon
    Caspers, Peter W. J.
    Visser, Loes E.
    Leufkens, Hubert G. M.
    Stricker, Bruno HCh
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (06) : 641 - 651
  • [9] Prevalence and Determinants of Multimorbidity, Polypharmacy, and Potentially Inappropriate Medication Use in the Older Outpatients: Findings from EuroAgeism H2020 ESR7 Project in Ethiopia
    Bhagavathula, Akshaya Srikanth
    Seid, Mohammed Assen
    Adane, Aynishet
    Gebreyohannes, Eyob Alemayehu
    Brkic, Jovana
    Fialova, Daniela
    [J]. PHARMACEUTICALS, 2021, 14 (09)
  • [10] The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective
    Bjornsson, TD
    Callaghan, JT
    Einolf, HJ
    Fischer, V
    Gan, L
    Grimm, S
    Kao, J
    King, SP
    Miwa, G
    Ni, L
    Kumar, G
    McLeod, J
    Obach, RS
    Roberts, S
    Roe, A
    Shah, A
    Snikeris, F
    Sullivan, JT
    Tweedie, D
    Vega, JM
    Walsh, J
    Wrighton, SA
    [J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (07) : 815 - 832